STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Abivax S.A. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Abivax SA (ABVX): Schedule 13G/A filed reporting passive ownership by TCG Crossover affiliates and Chen Yu. The filing lists 7,111,596 Abivax ADSs beneficially owned by Chen Yu, equal to 9.1% of the ordinary shares. TCG Crossover Fund I holds 6,456,596 ADSs (8.3%), and TCG Crossover Fund II holds 655,000 ADSs (0.8%).

Each ADS represents one ordinary share. Percentages are based on 77,830,067 ordinary shares outstanding as of September 30, 2025. The reporting persons disclaim group status and certify the securities were not acquired to change or influence control.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 6,456,596 ordinary shares (as defined in Item 2(d) below) in the form of American Depositary Shares ("ADSs") of the Issuer (as defined in Item 1(a) below) held of record by TCG Crossover I (as defined in Item 2(a) below). Each ADS represents one (1) ordinary share. TCG Crossover GP I (as defined in Item 2(a) below) is the general partner of TCG Crossover I and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP I and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 77,830,067 ordinary shares outstanding as of September 30, 2025, as provided to the Reporting Persons by the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 6,456,596 ordinary shares in the form of ADSs of the Issuer held of record by TCG Crossover I. Each ADS represents one (1) ordinary share. TCG Crossover GP I is the general partner of TCG Crossover I and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP I and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 77,830,067 ordinary shares outstanding as of September 30, 2025, as provided to the Reporting Persons by the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 655,000 ordinary shares in the form of ADSs of the Issuer held of record by TCG Crossover II (as defined in Item 2(a) below). Each ADS represents one (1) ordinary share. TCG Crossover GP II (as defined in Item 2(a) below) is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 77,830,067 ordinary shares outstanding as of September 30, 2025, as provided to the Reporting Persons by the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 655,000 ordinary shares in the form of ADSs of the Issuer held of record by TCG Crossover II. Each ADS represents one (1) ordinary share. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 77,830,067 ordinary shares outstanding as of September 30, 2025, as provided to the Reporting Persons by the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 6,456,596 ordinary shares in the form of ADSs of the Issuer held of record by TCG Crossover I and (ii) 655,000 ordinary shares in the form of ADSs of the Issuer held of record by TCG Crossover II. TCG Crossover GP I is the general partner of TCG Crossover I and may be deemed to have voting, investment, and dispositive power with respect to the securities held of record by TCG Crossover I. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to the securities held of record by TCG Crossover II. Chen Yu is the sole managing member of each of TCG Crossover GP I and TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to the securities held of record by TCG Crossover II and TCG Crossover II. Based on 77,830,067 ordinary shares outstanding as of September 30, 2025, as provided to the Reporting Persons by the Issuer.


SCHEDULE 13G



TCG Crossover GP I, LLC
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/14/2025
TCG Crossover Fund I, L.P.
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/14/2025
TCG Crossover GP II, LLC
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/14/2025
TCG Crossover Fund II, L.P.
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/14/2025
Chen Yu
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, as Attorney-in-Fact for Chen Yu
Date:11/14/2025

FAQ

What did Abivax (ABVX) disclose in this Schedule 13G/A?

It reports passive beneficial ownership by TCG Crossover affiliates and Chen Yu totaling 7,111,596 ADSs, or 9.1% of ordinary shares.

How many Abivax shares does TCG Crossover Fund I report?

TCG Crossover Fund I reports 6,456,596 ADSs, representing 8.3% of Abivax’s ordinary shares.

How many Abivax shares does TCG Crossover Fund II report?

TCG Crossover Fund II reports 655,000 ADSs, representing 0.8% of the class.

What is Chen Yu’s reported beneficial ownership in ABVX?

Chen Yu is reported as beneficially owning 7,111,596 ADSs, or 9.1% of the ordinary shares.

What share count was used to calculate the ownership percentages?

Percentages are based on 77,830,067 ordinary shares outstanding as of September 30, 2025.

Is this a passive or active ownership filing for ABVX?

It includes a certification consistent with passive ownership (13G), stating no intent to change or influence control.

Do Abivax ADSs equal ordinary shares in this filing?

Yes. The filing states each ADS represents one ordinary share.
Abivax S.A.

NASDAQ:ABVX

ABVX Rankings

ABVX Latest News

ABVX Latest SEC Filings

ABVX Stock Data

7.85B
77.83M
43.25%
2.15%
Biotechnology
Healthcare
Link
France
Paris